Forget chasing the next Pfizer: Singapore’s biotech future lies in innovation, not giants

Singapore may never mint a Novo Nordisk – and that’s not necessarily a failure. Two and a half decades into its biopharmaceutical push, Singapore has built a strong research base, even if a home-grown champion remains elusive. #Brunch

What's the future of Singapore’s biotech industry? https://bt.sg/gWBz